GSK Investigational Site

Reykjavik IS-101

0 studies enrolling now · 4 studies all time

What they study most

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Carcinoma of Breast, Herpes Simplex, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Neoplasms, Breast, Ovarian Neoplasms, Prostatic Hyperplasia, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients — Stopped early
• Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed